High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial (Q43091848)
Jump to navigation
Jump to search
scientific article published in May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial |
scientific article published in May 2010 |
Statements
1 reference
High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial (English)
1 reference
Jos N Hoes
1 reference
Johannes W G Jacobs
1 reference
Harry M J Hulsmans
1 reference
Ron N J De Nijs
1 reference
Willem F Lems
1 reference
George A W Bruyn
1 reference
Piet P M M Geusens
1 reference
Johannes W J Bijlsma
1 reference
1 May 2010
1 reference
1 reference